Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Compositions and methods for inhibiting expression of transthyretin
No-Receipt date
2019-00586 - 11/02/2019
No-Filing date
20190800004 - 11/02/2019
No-Granting date
8000767 - 25/06/2020
No-EPO application date
-
No-EPO granting date
-
Gazette No-Publication date of application
6/2019 - 08/07/2019
Gazette No-Publication date of granted patent
6/2020 - 16/07/2020
Expiration date
30/08/2033
Kind of title
Supplementary Protection Certificate for Medicinal Products
Legal status
VALID
Priorities
US106956 P20/10/2008/US
US115738 P18/11/2008/US
US156670 P02/03/2009/US
US185545 P09/06/2009/US
US242783 P15/09/2009/US
US244794 P22/09/2009/US
Active Substance of Supplementary Certificates
PATISIRAN
IPC Classification
Related Documents
Related Titles
Type
Master title
Related title
[SPC]
20180400163
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
835965
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET, 3RD FLOOR
CAMBRIDGE, MA 02142
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
2070291
SAH, DINAH WEN-YEE
2070292
HINKLE, GREGORY
2070293
ALVAREZ, RENE
2070294
MILSTEIN, STUART
2070295
CHEN, QINGMIN
Representatives
Code
Firstname
Surname
Address
Town
Zip
3464
EFANGELIA
GIAZITZOGLOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
9/4/2020 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡΣΗ & ΑΝΤΙΚ/ΣΤΑΣΗ ΠΛΗΡΕΞ./ΑΝΤΙΚΛΗΤΟΥ
Payments history
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).